ReviewCancers2020

Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis.

Wieke C H Visser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.